ibo: the income statement

MyFinsight

IMPACT BIOMEDICAL INC. (IBO)

For the quarter ending 2025-06-30, IBO made $7K in revenue. -$14,346K in net income. Net profit margin of -204942.86%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Total revenue	7
Sales, general and administrative compensation (inclusive of stock-based compensation)	246
Sales and marketing	1
Research and development	75
Professional fees	411
Other operating expenses	110
Depreciation and amortization	288
Cost of revenue	11
Rent and utilities	18
Total costs and expenses	1,160
Operating loss	-1,153
Interest income	3
Interest expense	260
Change in fair value of note payable, related party	12,942
Loss from operations before income taxes	-14,352
Income tax benefit (expense)	-
Net loss	-14,352
Income (loss) from operations attributed to non-controlling interest	-6
Net loss attributable to common stockholders	-14,346

Basic	-1.18
Basic	12,185,412
Diluted	-1.18

Unit: Thousand (K) dollars (except for numbers of shares and EPS)